Targeting the NLRP3 inflammasome-IL-1β pathway in type 2 diabetes and obesity.

Diabetologia · 2025 · PMC11663173 · PMID 39496966

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp <0.00001actually significant

A meta-analysis of 2921 participants with type 2 diabetes treated with an IL-1-blocking therapy showed a highly significant reduction in HbA 1c ( p <0.00001 [ 88 ]).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.